1. Home
  2. NCNA vs CHNR Comparison

NCNA vs CHNR Comparison

Compare NCNA & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNA
  • CHNR
  • Stock Information
  • Founded
  • NCNA 1997
  • CHNR N/A
  • Country
  • NCNA United Kingdom
  • CHNR China
  • Employees
  • NCNA N/A
  • CHNR N/A
  • Industry
  • NCNA Biotechnology: Pharmaceutical Preparations
  • CHNR Precious Metals
  • Sector
  • NCNA Health Care
  • CHNR Basic Materials
  • Exchange
  • NCNA Nasdaq
  • CHNR Nasdaq
  • Market Cap
  • NCNA 4.5M
  • CHNR 4.6M
  • IPO Year
  • NCNA 2017
  • CHNR 1995
  • Fundamental
  • Price
  • NCNA $0.04
  • CHNR $3.40
  • Analyst Decision
  • NCNA Buy
  • CHNR
  • Analyst Count
  • NCNA 2
  • CHNR 0
  • Target Price
  • NCNA $25.00
  • CHNR N/A
  • AVG Volume (30 Days)
  • NCNA 296.1M
  • CHNR 82.4K
  • Earning Date
  • NCNA 08-14-2025
  • CHNR 05-15-2025
  • Dividend Yield
  • NCNA N/A
  • CHNR N/A
  • EPS Growth
  • NCNA N/A
  • CHNR N/A
  • EPS
  • NCNA N/A
  • CHNR N/A
  • Revenue
  • NCNA N/A
  • CHNR N/A
  • Revenue This Year
  • NCNA N/A
  • CHNR N/A
  • Revenue Next Year
  • NCNA N/A
  • CHNR N/A
  • P/E Ratio
  • NCNA N/A
  • CHNR N/A
  • Revenue Growth
  • NCNA N/A
  • CHNR N/A
  • 52 Week Low
  • NCNA $0.03
  • CHNR $3.21
  • 52 Week High
  • NCNA $10.79
  • CHNR $9.04
  • Technical
  • Relative Strength Index (RSI)
  • NCNA 36.10
  • CHNR 40.05
  • Support Level
  • NCNA $0.04
  • CHNR $3.36
  • Resistance Level
  • NCNA $0.07
  • CHNR $4.73
  • Average True Range (ATR)
  • NCNA 0.01
  • CHNR 0.37
  • MACD
  • NCNA 0.00
  • CHNR -0.01
  • Stochastic Oscillator
  • NCNA 12.79
  • CHNR 12.50

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

About CHNR China Natural Resources Inc.

China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.

Share on Social Networks: